These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. European Medicines Agency changes policy on clinical trial data publication. Watson R BMJ; 2014 Jun; 348():g4073. PubMed ID: 24938275 [No Abstract] [Full Text] [Related]
4. The pioneers of transparency. Adams B BMJ; 2015 Jan; 350():g7717. PubMed ID: 25555823 [No Abstract] [Full Text] [Related]
5. European Ombudsman ramps up action against European Medicines Agency over data transparency plans. Torjesen I BMJ; 2014 Jun; 348():g3733. PubMed ID: 24904032 [No Abstract] [Full Text] [Related]
6. Europe's drug agency will publish clinical trial data for new products from 2014. Torjesen I BMJ; 2012 Nov; 345():e8061. PubMed ID: 23183072 [No Abstract] [Full Text] [Related]
7. Clinical trial transparency: many gains but access to evidence for new medicines remains imperfect. Mintzes B; Lexchin J; Quintano AS Br Med Bull; 2015; 116():43-53. PubMed ID: 26493102 [TBL] [Abstract][Full Text] [Related]
8. Redacted policy on sharing drug trial data in Europe. Groves T; Weber W BMJ; 2014 May; 348():g3561. PubMed ID: 24870506 [No Abstract] [Full Text] [Related]
9. Clinical trial data: to disclose or not to disclose? Bouchie A Nat Biotechnol; 2006 Sep; 24(9):1058-60. PubMed ID: 16964203 [No Abstract] [Full Text] [Related]
10. EMA consults public on plan to increase transparency of drug trial data. Cohen D BMJ; 2013 Jun; 346():f4124. PubMed ID: 23804186 [No Abstract] [Full Text] [Related]
11. European Union Clinical Trials Register: on the way to more transparency of clinical trial data. Egger GF; Herold R; Rodriguez A; Manent N; Sweeney F; Saint Raymond A Expert Rev Clin Pharmacol; 2013 Sep; 6(5):457-9. PubMed ID: 23971872 [No Abstract] [Full Text] [Related]
12. European drug agency sets out plans to publish clinical trial data from 2014. Watson R BMJ; 2012 Dec; 345():e8423. PubMed ID: 23236049 [No Abstract] [Full Text] [Related]
13. European Federation of Statisticians in the Pharmaceutical Industry's position on access to clinical trial data. Fletcher C; Driessen S; Burger HU; Gerlinger C; Biesheuvel E; Pharm Stat; 2013; 12(6):333-6. PubMed ID: 24136872 [TBL] [Abstract][Full Text] [Related]
14. Clinical trial transparency and orphan drug development: recent trends in data sharing by the pharmaceutical industry. So D; Joly Y; Knoppers BM Public Health Genomics; 2013; 16(6):322-35. PubMed ID: 24503593 [TBL] [Abstract][Full Text] [Related]
15. The European Medicines Agency's plans for sharing data from clinical trials. Groves T; Godlee F BMJ; 2013 May; 346():f2961. PubMed ID: 23657192 [No Abstract] [Full Text] [Related]
16. Big strides in Europe towards clinical trial transparency. Groves T BMJ; 2014 Oct; 349():g6276. PubMed ID: 25331626 [No Abstract] [Full Text] [Related]
17. Access to data: EMA in key position. Prescrire Int; 2015 May; 24(160):139. PubMed ID: 26034809 [TBL] [Abstract][Full Text] [Related]
18. EMA's proposal to vet drug research that uses its data is "outdated," say critics. Kmietowicz Z BMJ; 2014 Aug; 349():g5076. PubMed ID: 25114275 [No Abstract] [Full Text] [Related]
19. Biomedicine. Pharma firms push for sharing of cancer trial data. Bhattacharjee Y Science; 2012 Oct; 338(6103):29. PubMed ID: 23042862 [No Abstract] [Full Text] [Related]
20. EFPIA-PhRMA's principles for clinical trial data sharing have been misunderstood. Doshi P BMJ; 2013 Aug; 347():f5164. PubMed ID: 23963563 [No Abstract] [Full Text] [Related] [Next] [New Search]